BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22203660)

  • 1. How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
    Obeyesekere MN; Klein GJ; Modi S; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Krahn AD
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):958-64. PubMed ID: 22203660
    [No Abstract]   [Full Text] [Related]  

  • 2. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Lambiase PD
    Europace; 2010 Feb; 12(2):158-9. PubMed ID: 20045864
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of ventricular repolarization abnormalities in congenital long QT syndrome.
    Rashba EJ
    J Cardiovasc Electrophysiol; 2004 May; 15(5):557-9. PubMed ID: 15149425
    [No Abstract]   [Full Text] [Related]  

  • 5. Brugada-like phenomenon, induced by intravenous propafenone, in a patient with idiopathic fascicular ventricular tachycardia.
    Pino R; Sciortino G; Polizzi G
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):380-3. PubMed ID: 20414118
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol.
    Ağaç MT; Erkan H; Korkmaz L
    Arch Cardiovasc Dis; 2014; 107(8-9):476-8. PubMed ID: 23791603
    [No Abstract]   [Full Text] [Related]  

  • 7. Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry.
    Krahn AD; Healey JS; Chauhan VS; Birnie DH; Champagne J; Sanatani S; Ahmad K; Ballantyne E; Gerull B; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Klein GJ; Gollob MH; Simpson CS; Talajic M; Gardner M
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):933-40. PubMed ID: 22944906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugada syndrome and idiopathic left ventricular tachycardia unmasked by exercise and a class Ic drug.
    Yuasa S; Sato M; Kitazawa H; Okabe M; Komatsu Y; Koshikawa T; Miyajima S; Aizawa Y
    J Electrocardiol; 2014; 47(5):721-4. PubMed ID: 24908473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious ups and downs.
    Chen SF; Yabumoto K; Haywood LJ
    Am J Med; 2010 Dec; 123(12):1094-6. PubMed ID: 20951367
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholaminergic polymorphic ventricular tachycardia in a child with Brugada pattern on ECG: one patient with two diseases?
    Janson CM; Ceresnak SR; Chung WK; Pass RH
    Heart Rhythm; 2014 Nov; 11(11):2101-4. PubMed ID: 25016147
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes.
    Antzelevitch C
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2024-38. PubMed ID: 17586620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited cardiac arrhythmias.
    Nat Rev Dis Primers; 2020 Jul; 6(1):59. PubMed ID: 32678096
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of ventricular tachycardia.
    Pellegrini CN; Scheinman MM
    Curr Probl Cardiol; 2010 Sep; 35(9):453-504. PubMed ID: 20887902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
    Svendsen JH; Geelen P;
    Europace; 2010 May; 12(5):741-2. PubMed ID: 20421225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac ion channelopathies: A potential link between cardiomyopathies and cardiac arrhythmias].
    Schimpf R; Rudic B; Tülümen E; Papavassiliu T; Dösch C; Borggrefe M
    Dtsch Med Wochenschr; 2013 Mar; 138(12):591-7. PubMed ID: 23483420
    [No Abstract]   [Full Text] [Related]  

  • 18. Right ventricular outflow tract tachycardia and polymorphic ventricular tachycardia.
    Lee SH; Shin DG; Hong GR; Park JS; Kim YJ; Shim BS
    Pacing Clin Electrophysiol; 2005 Mar; 28(3):231-4. PubMed ID: 15733184
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone-induced long QT and polymorphic ventricular tachycardia.
    Nkomo VT; Shen WK
    Am J Emerg Med; 2001 May; 19(3):246-8. PubMed ID: 11326361
    [No Abstract]   [Full Text] [Related]  

  • 20. Outflow tract ventricular arrhythmias: An update.
    Lerman BB
    Trends Cardiovasc Med; 2015 Aug; 25(6):550-8. PubMed ID: 25846938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.